Teva Shifts Strategy In Japan
Teva Takeda Divests To Nichi-Iko; Focuses On Complex Generics And Specialty
Teva has announced a major strategic shift in Japan, with its Teva Takeda Pharma joint venture striking a deal to divest the majority of its traditional generics business to Nichi-Iko so that it can focus instead on complex generics and specialty products.
